from Breakingviews:

Alere board’s diligence brings 51 pct premium

February 1, 2016

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Financial Regulatory Forum:

IMPACT ANALYSIS: Second phase audits of patient-privacy compliance starting under U.S. health agency

By Guest Contributor
January 26, 2016

By Elizabeth Polking, Regulatory Intelligence

(Thomson Reuters Regulatory Intelligence) - Hundreds of U.S. health-care providers over the next three years will be scrutinized for their compliance with patient privacy regulations, as regulators respond to findings of widespread compliance gaps and launch a new round of industry audits.

from Breakingviews:

Healthcare M&A will wear down in 2016

January 4, 2016

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Financial Regulatory Forum:

COMMENTARY: Insurance mergers face U.S. regulatory uncertainty despite inversions clarification

By Guest Contributor
December 28, 2015

By Lawrence Hsieh, Practical Law

Although the pharmaceutical industry has drawn a lot of the attention given to corporate inversions, the regulatory environment for these tax-saving corporate relocation transactions also affects insurance mergers.

from Breakingviews:

Theranos’ wounded credibility hobbles all unicorns

December 21, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Sanofi and Boehringer scratch each others’ backs

December 15, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Pfizer’s $150 bln plan is high-risk, low-benefit

November 19, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Biotech firm’s stock buyback emits bad bouquet

November 12, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Shire pays up for easier prey than Baxalta

November 2, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own. 

from Breakingviews:

Testing simplifier Theranos complicates governance

October 29, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.